Meda Asserts Independence with US$3.1 B Rottapharm Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 9 (Table of Contents)
Published: 11 Sep-2014
DOI: 10.3833/pdr.v2014.i9.2060 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Having rejected two takeover bids from Mylan earlier in 2014, Sweden’s Meda has agreed to acquire the Italian speciality pharmaceutical company Rottapharm Madaus for a total consideration of SEK21...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS